Chaganti Raju S.K. 4
4 · CANCER GENETICS, INC · Filed Apr 12, 2013
Insider Transaction Report
Form 4
Chaganti Raju S.K.
Director
Transactions
- Conversion
Convertible Note
2013-04-10→ 0 totalExercise: $10.00→ Common Stock (13,430 underlying) - Purchase
Convertible Note
2013-04-10+13,430→ 438,727 total
Footnotes (1)
- [F1]The outstanding principal balance under the convertible note plus all accrued and unpaid interest thereon converted into shares of common stock of Cancer Genetics, Inc. (the "Company") upon consummation of the Company's initial public offering at a conversion price per share equal to the initial public offering price per share. The convertible note had no expiration date.